Please login to the form below

Not currently logged in
Email:
Password:

Arquer Diagnostics appoints CEO

Nadia Whittley takes up the lead role at the oncology diagnostics firm

Arquer Diagnostics Nadia WhittleySunderland, UK-based Arquer Diagnostics has appointed Nadia Whittley as its new chief executive officer with immediate effect.

Whittley joins the oncology diagnostic specialist from Tefen Management Consulting, where she was partner and managing director, Europe, responsible for the strategic direction of the company's life science business unit across EMEA.

Previously, she has served as chief executive of Alium Medical, a UK-based global supply service, managing director of medical devices, EMEA at Allergan, and marketing director for interventional cardiology, EMEA at Boston Scientific International.

Dr Sandy Primrose, chairman of Arquer Diagnostics, said: “I would like to welcome Nadia and am delighted that we have someone with her commercial background as our new chief executive officer.

“Her experience of successfully launching new technologies across multiple regions and her knowledge of the sector make her a real asset to the business, particularly as we move forward to commercialise our MCM5-ELISA diagnostic test.”

15th December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics